Krohn KA - Search Results

1

Multiagent PET for risk characterization in sarcoma.

Eary JF, Link JM, Muzi M, Conrad EU, Mankoff DA, White JK, Krohn KA. Eary JF, et al. Among authors: krohn ka. J Nucl Med. 2011 Apr;52(4):541-6. doi: 10.2967/jnumed.110.083717. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421714 Free PMC article.

2

2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.

Spence AM, Muzi M, Graham MM, O'Sullivan F, Link JM, Lewellen TK, Lewellen B, Freeman SD, Mankoff DA, Eary JF, Krohn KA. Spence AM, et al. Among authors: krohn ka. Clin Cancer Res. 2002 Apr;8(4):971-9. Clin Cancer Res. 2002. PMID: 11948102 Clinical Trial.

3

The FDG lumped constant in normal human brain.

Graham MM, Muzi M, Spence AM, O'Sullivan F, Lewellen TK, Link JM, Krohn KA. Graham MM, et al. Among authors: krohn ka. J Nucl Med. 2002 Sep;43(9):1157-66. J Nucl Med. 2002. PMID: 12215553 Free article.

4

Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.

Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomily RC, Hummel S, Scharnhorst J, Krohn KA, Spence AM. Tralins KS, et al. Among authors: krohn ka. J Nucl Med. 2002 Dec;43(12):1667-73. J Nucl Med. 2002. PMID: 12468518 Free article. Clinical Trial.

5

Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results.

Wells JM, Mankoff DA, Eary JF, Spence AM, Muzi M, O'Sullivan F, Vernon CB, Link JM, Krohn KA. Wells JM, et al. Among authors: krohn ka. Mol Imaging. 2002 Jul;1(3):145-50. doi: 10.1162/15353500200202115. Mol Imaging. 2002. PMID: 12920852

6

Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis.

Wells JM, Mankoff DA, Muzi M, O'Sullivan F, Eary JF, Spence AM, Krohn KA. Wells JM, et al. Among authors: krohn ka. Mol Imaging. 2002 Jul;1(3):151-9. doi: 10.1162/15353500200202112. Mol Imaging. 2002. PMID: 12920853

7

18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA. Vesselle H, et al. Among authors: krohn ka. J Nucl Med. 2003 Sep;44(9):1482-8. J Nucl Med. 2003. PMID: 12960196 Free article. Clinical Trial.

8

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Rajendran JG, Mankoff DA, O'Sullivan F, Peterson LM, Schwartz DL, Conrad EU, Spence AM, Muzi M, Farwell DG, Krohn KA. Rajendran JG, et al. Among authors: krohn ka. Clin Cancer Res. 2004 Apr 1;10(7):2245-52. doi: 10.1158/1078-0432.ccr-0688-3. Clin Cancer Res. 2004. PMID: 15073099

9

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA. Spence AM, et al. Among authors: krohn ka. J Nucl Med. 2004 Oct;45(10):1653-9. J Nucl Med. 2004. PMID: 15471829 Free article. Clinical Trial.

10

PET imaging of cellular proliferation.

Mankoff DA, Shields AF, Krohn KA. Mankoff DA, et al. Among authors: krohn ka. Radiol Clin North Am. 2005 Jan;43(1):153-67. doi: 10.1016/j.rcl.2004.09.005. Radiol Clin North Am. 2005. PMID: 15693654 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters